{"filing":{"accession_number":"0001493152-26-035196","cik":"0000714256","ticker":"SMTI","company_name":"Sanara MedTech Inc.","form":"8-K","filing_date":"2026-07-29","report_date":"2026-07-29","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/714256/000149315226035196/form8-k.htm"},"events":[{"id":21856,"run_id":19723,"accession_number":"0001493152-26-035196","anchor_item_number":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.99,"summary":"The filing discloses entry into a definitive merger agreement on July 29, 2026, under which MiMedx Group, Inc. will acquire all outstanding shares of Sanara MedTech Inc. in a cash and stock transaction valued at $35 per share with a total enterprise value of approximately $350 million. Item 1.01 explicitly covers \"Entry into a Material Definitive Agreement,\" and the merger consideration ($33 cash + 0.4735 MDXG shares per SMTI share) and strategic rationale (expansion of surgical footprint, nearly doubling surgical revenue, $20M+ cost synergies) clearly constitute a material acquisition transaction.","company_name":"Sanara MedTech Inc.","ticker":"SMTI","filing_date":"2026-07-29","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":21603,"accession_number":"0001493152-26-035196","item_number":null,"item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.99,"reasoning":"The filing discloses entry into a definitive merger agreement on July 29, 2026, under which MiMedx Group, Inc. will acquire all outstanding shares of Sanara MedTech Inc. in a cash and stock transaction valued at $35 per share with a total enterprise value of approximately $350 million. Item 1.01 explicitly covers \"Entry into a Material Definitive Agreement,\" and the merger consideration ($33 cash + 0.4735 MDXG shares per SMTI share) and strategic rationale (expansion of surgical footprint, nearly doubling surgical revenue, $20M+ cost synergies) clearly constitute a material acquisition transaction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-30T02:18:57.881438+00:00","company_name":"Sanara MedTech Inc.","ticker":"SMTI","filing_date":"2026-07-29"}]}